NIB101

· Noile-Immune Biotech, Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NIB101, covering 2025-05-23 to 2025-05-23. Get the full timeline:

Most recent: Clinical Trial Update: Study of NIB101 in Participants With Advanced Solid Tumors [Phase 1]